Glucagon-Like Peptide-1 Receptor Agonists in Hidradenitis Suppurativa

This cohort study investigates the potential therapeutic benefits of glucagon-like peptide-1 receptor agonists in patients with hidradenitis suppurativa.

Corresponding Author: Florence Poizeau, MD, PhD, Department of Dermatology, Rennes University Hospital, 2 rue Henri le Guilloux 35000 Rennes, France (florence.poizeau@chu-rennes.fr).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.